cancer patients can they w ait
play

Cancer Patients, can they w ait? Dr. Sunil Skaria Consultant - PowerPoint PPT Presentation

Mar 16, 2024 •308 likes •499 views

Cancer Patients, can they w ait? Dr. Sunil Skaria Consultant Oncologist MRCP(UK), MRCP(Ireland),FRCR, ESMO, MSc(Healthcare leadership) Clinical Lead, Oncology, Spire Specialist Centre Consultant Clinical Oncologist, Mid Essex Hospital Services

  1. Cancer Patients, can they w ait? Dr. Sunil Skaria Consultant Oncologist MRCP(UK), MRCP(Ireland),FRCR, ESMO, MSc(Healthcare leadership) Clinical Lead, Oncology, Spire Specialist Centre Consultant Clinical Oncologist, Mid Essex Hospital Services NHS Trust. Honorary Consultant Oncologist, Colchester Hospital University NHS Foundation Trust

  3. Current Landscape of Cancer 3

  4. Can they wait? Waiting targets • For initial diagnosis? • For treatment? • For suspected recurrence or metastases? • For treatment related complications?

  5. Rising burden of cancer • Cancer services cost 6.7 billion /year 2012- 13 (National audit office) • Projected cost for 2020 - 13 billion • Early diagnosis may allow at least 11000 patients per year surviving cancer by 2020 BUPA Cancer Care 2020 5

  6. Why can not they wait? • Performance status and quality of life • Exponential growth ( cancer recovery secrets) • Survival outcome • Better treatment options

  10. Pertuzumab/Herceptin/Doc etaxel

  11. Immune related Adverse Events Endocrine- Neurological- Thyroid, neuropathy, Gastro- Colitis Adrenal, Myaesthenia, pituitary Guillain Barre Renal-Nephritis, Skin- rash, Pulmonary- acute renal Steven Pneumonitis failure Johnsons, TEN Cardiology - Myocarditis, Hypersensitivity Hepatitis pericarditis

  12. PET/CT Fusion CT based GTV PET/CT based GTV

  16. Tumour markers • CEA • PSA • AFP, HCG,LDH • CA19.9 • CA15.3

  17. 6 basic human psychological needs* • Love / Connection • Value / significance • Clarity/ certainty • Variety • Growth • Contribution *Ref- Executive Decisions Dr. Sunil Skaria

  18. Thank you 18

Recommend

Counseling Patients Experiencing Financial Toxicity Dan Sherman, MA. LPC Cancer patients

Counseling Patients Experiencing Financial Toxicity Dan Sherman, MA. LPC Cancer patients

Counseling Patients Experiencing Financial Toxicity Dan Sherman, MA. LPC Cancer patients demonstrate more anxiety over the cost of treatment than over dying from their disease . Oncology Times, August 2009 42% of insured cancer patients

332 views • 30 slides
Quick review of patients are .. pharmacokinetic-based The concentration-effect (i.e.,

Quick review of patients are .. pharmacokinetic-based The concentration-effect (i.e.,

Awareness of drug interactions increasing in patients with cancer Drug Interactions in Stem Prevalence in HSCT patients Cell Transplantation unknown 4.5-58% in cancer patients Numerous electronic databases exist with variable

249 views • 8 slides
Patients in the Genomic Era Marc Lippman, MD The Sylvester Comprehensive Cancer Center at the

Patients in the Genomic Era Marc Lippman, MD The Sylvester Comprehensive Cancer Center at the

Selecting Therapy for Breast Cancer Patients in the Genomic Era Marc Lippman, MD The Sylvester Comprehensive Cancer Center at the University of Miami PERSONALIZED MEDICINE FOR BREAST CANCER PATIENTS A WORKING DEFINITION: SUFFICIENT

764 views • 62 slides
Navigating patients through lung cancer treatment Kirsten Mooney -Thoracic Cancer Nurse

Navigating patients through lung cancer treatment Kirsten Mooney -Thoracic Cancer Nurse

Navigating patients through lung cancer treatment Kirsten Mooney -Thoracic Cancer Nurse Coordinators Caitlin Broderick Lung Cancer an overview Most recent stats from WA Cancer Registry (2013) Incidence 1000 cases, Death 788

330 views • 15 slides
60% 78% H&N 705,781 18M 60% Prostate 1,276,106 61% Rectum 704,376 new patients per

60% 78% H&N 705,781 18M 60% Prostate 1,276,106 61% Rectum 704,376 new patients per

RECEIVING RTx NUMBER OF PATIENTS 83% Breast cancer 2,088,849 76% Lung cancer 2,093,876 60% 78% H&N 705,781 18M 60% Prostate 1,276,106 61% Rectum 704,376 new patients per year 57% Pancreas 458,918 92% CNS 296,851 Inadequate

730 views • 47 slides
Breast Cancer Path of Support Milestones for Empowering and Assisting Breast Cancer Patients

Breast Cancer Path of Support Milestones for Empowering and Assisting Breast Cancer Patients

Breast Cancer Path of Support Milestones for Empowering and Assisting Breast Cancer Patients I lana Kadmon (RN, PhD) The Israel Cancer Association 1 Promoting the fight against breast cancer I CAs Aim: Reducing breast cancer

555 views • 23 slides
Breast Cancer Molecular Subtypes Patients and Tumors Between Patients: subtypes How to use

Breast Cancer Molecular Subtypes Patients and Tumors Between Patients: subtypes How to use

Breast Cancer Heterogeneity Breast Cancer Molecular Subtypes Patients and Tumors Between Patients: subtypes How to use Molecular Diagnostic Tests in Breast Diseases Laura J. van t Veer Within Tumors: subclones University of California, San

356 views • 8 slides
WORKING WITH YOUNG CANCER PATIENTS FROM EXPERIENCE TO ACTIVITY WHAT DOES A CHILD WITH CANCER

WORKING WITH YOUNG CANCER PATIENTS FROM EXPERIENCE TO ACTIVITY WHAT DOES A CHILD WITH CANCER

WORKING WITH YOUNG CANCER PATIENTS FROM EXPERIENCE TO ACTIVITY WHAT DOES A CHILD WITH CANCER NEED (I) Non-medical support Constant care form specialists Rehabilitation and parents Complex Education and CHILD treatment development

340 views • 14 slides
Independent Cancer Patients Voice Access and Consent in Biobanking Workshop Newcastle 10 th

Independent Cancer Patients Voice Access and Consent in Biobanking Workshop Newcastle 10 th

Independent Cancer Patients Voice Access and Consent in Biobanking Workshop Newcastle 10 th October 2012 Response to the NCRI Template for Access Christine Allmark Independent Cancer Patients Voice Independent Cancer Patients Voice

299 views • 8 slides
Update on Adjuvant and Salvage Options for Patients with Kidney Cancer A Ari Hakimi, MD

Update on Adjuvant and Salvage Options for Patients with Kidney Cancer A Ari Hakimi, MD

Update on Adjuvant and Salvage Options for Patients with Kidney Cancer A Ari Hakimi, MD Assistant Attending, Dept of Surgery, Urology Sidney Kimmel Center for Prostate and Urologic Cancer Memorial Sloan Kettering Cancer Center, New York

480 views • 30 slides
IAEA Support for Radiotherapy Services for Patients with Cervical Cancer Kirsten Hopkins Applied

IAEA Support for Radiotherapy Services for Patients with Cervical Cancer Kirsten Hopkins Applied

Gynecologic Cancer InterGroup Cervix Cancer Research Network IAEA Support for Radiotherapy Services for Patients with Cervical Cancer Kirsten Hopkins Applied Radiation Biology and Radiotherapy Section Division of Human Health Cervix Cancer

358 views • 17 slides
Visualizing Prostate Cancer Patients Treated with Three- Dimensional Computed Tomography-Guided

Visualizing Prostate Cancer Patients Treated with Three- Dimensional Computed Tomography-Guided

Visualizing Prostate Cancer Patients Treated with Three- Dimensional Computed Tomography-Guided Brachytherapy Faleh Al-shameri (falshame@gmu.edu) Jee Vang (jvang@gmu.edu) Interface,2004 Background on Prostate Cancer Most common cancer

451 views • 15 slides
Engaging the corporate sector to support cancer patients - The Australian

Engaging the corporate sector to support cancer patients - The Australian

Engaging the corporate sector to support cancer patients - The Australian experience " Paula Vallentine Manager, Direct Cancer Services, CISS Cancer Council NSW Where we are situated " Where we are situated "

491 views • 16 slides
Small Cell Lung Cancer, or Head and Neck cancer patients receiving eftilagimod alpha (a soluble

Small Cell Lung Cancer, or Head and Neck cancer patients receiving eftilagimod alpha (a soluble

Poster Board: 18 LB-394 Initial results from a Phase II study (TACTI-002) in Non- Small Cell Lung Cancer, or Head and Neck cancer patients receiving eftilagimod alpha (a soluble LAG-3 protein) and pembrolizumab 27 th April 2020 Presenting

264 views • 7 slides
Epithelial Ovarian Cancer (EOC) 5 th commonest cause of female cancer death 1300 new cases

Epithelial Ovarian Cancer (EOC) 5 th commonest cause of female cancer death 1300 new cases

Epithelial Ovarian Cancer (EOC) 5 th commonest cause of female cancer death 1300 new cases in Australia per year Patients with extensive disease can have surgery Most patients disease returns within 2-5 years Desperate need

195 views • 7 slides
NAC FOR cN1 BREAST CANCER PATIENTS - NO Stephen R. Grobmyer, MD, FACS Professor of Surgery Zapis

NAC FOR cN1 BREAST CANCER PATIENTS - NO Stephen R. Grobmyer, MD, FACS Professor of Surgery Zapis

TARGETED AXILLARY DISSECTION FOLLOWING NAC FOR cN1 BREAST CANCER PATIENTS - NO Stephen R. Grobmyer, MD, FACS Professor of Surgery Zapis Endowed Chair for Breast Cancer Research Co-Leader, Breast Cancer Program Cleveland Clinic Cleveland, Ohio

392 views • 17 slides
Management of Patients with Her2+ve Brain metastases Her2+ve patients 15% of all breast cancer

Management of Patients with Her2+ve Brain metastases Her2+ve patients 15% of all breast cancer

Management of Patients with Her2+ve Brain metastases Her2+ve patients 15% of all breast cancer Even with adjuvant trastuzumab 10-15% relapse Trastuzumab does not cross BBB Management dependent on number of metastases Patients

583 views • 17 slides
INTENSITY OF POST-TREATMENT SURVEILLANCE AND SURVIVAL IN COLORECTAL CANCER PATIENTS George J.

INTENSITY OF POST-TREATMENT SURVEILLANCE AND SURVIVAL IN COLORECTAL CANCER PATIENTS George J.

INTENSITY OF POST-TREATMENT SURVEILLANCE AND SURVIVAL IN COLORECTAL CANCER PATIENTS George J. Chang, MD, MS, FACS, FASCRS Professor of Surgical Oncology & of Health Services Research The University of Texas, MD Anderson Cancer Center

204 views • 16 slides
Exercise for Cancer Patients and Survivors Kerry S. Courneya, PhD Professor and Canada Research

Exercise for Cancer Patients and Survivors Kerry S. Courneya, PhD Professor and Canada Research

Exercise for Cancer Patients and Survivors Kerry S. Courneya, PhD Professor and Canada Research Chair in Physical Activity and Cancer Director, Behavioral Medicine Laboratory Faculty of Kinesiology, Sport, and Recreation University of

802 views • 30 slides
High Dose Rate Brachytherapy for Cancer of the Oesophagus (gullet) Information for Patients

High Dose Rate Brachytherapy for Cancer of the Oesophagus (gullet) Information for Patients

High Dose Rate Brachytherapy for Cancer of the Oesophagus (gullet) Information for Patients Northern Centre for Cancer Care (NCCC) Freeman Hospital Introduction Your doctor has decided that you should have internal radiotherapy (also known

55 views • 4 slides
versus standard chemoradiation alone in patients with locally advanced cervical cancer Chief

versus standard chemoradiation alone in patients with locally advanced cervical cancer Chief

Gynaecologic Cancer Intergroup Cervix Cancer Research Network A phase III multicentre trial of weekly induction chemotherapy followed by standard chemoradiation versus standard chemoradiation alone in patients with locally advanced cervical

174 views • 15 slides
Mechanism underlying individual radiosensitivity of breast and head and neck cancer patients

Mechanism underlying individual radiosensitivity of breast and head and neck cancer patients

Mechanism underlying individual radiosensitivity of breast and head and neck cancer patients Siamak Haghdoost Centre for Radiation Protection Research Stockholm University WP6 DoReMi Individual variability in susceptibility to cancer (WP 6)

400 views • 22 slides
Liquid biopsies: monitoring patients with breast cancer and non-small cell lung cancer Jacqui

Liquid biopsies: monitoring patients with breast cancer and non-small cell lung cancer Jacqui

Liquid biopsies: monitoring patients with breast cancer and non-small cell lung cancer Jacqui Shaw, Director Leicester Precision Medicine Institute email: js39@Leicester.ac.uk; LPMI@leicester.ac.uk https://www2.le.ac.uk/institutes/lpmi

475 views • 20 slides
Cancer Program m e Board Patient-Centred Cancer Services Patient-Centred Care Project Aim s To

Cancer Program m e Board Patient-Centred Cancer Services Patient-Centred Care Project Aim s To

Cancer Program m e Board Patient-Centred Cancer Services Patient-Centred Care Project Aim s To improve experience and quality of care for patients Scope Breast cancer Lung cancer Gynaecological cancer Colorectal cancer

462 views • 6 slides

More recommend